Summer Replay: Community Acquired Pneumonia and Skin Infections

Subscribe on iTunes

Aired April 23: Empiric antibiotic choices for community acquired pnuemonia and clindamycin versus trimethoprim-sulfamethoxazole for skin and soft tissue infections.

Fahad and Amol want you to understand the following:

1. A large, high quality RCT showed that there was no significant difference between an empiric treatment strategy of beta-lactam vs beta-lactam plus macrolide vs respiratory fluoroquinolone for the treatment of community-acquired pneumonia requiring hospitalization in a non-ICU setting. 

2. A high quality RCT showed that there was no significant difference between clindamycin and TMP-SMX, with respect to either efficacy or side-effect profile, for the treatment of uncomplicated skin infections in regions with endemic Methicillin-Resistant Staphylococcus Aureus. 

The papers

DF Postma et al. Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults. N Engl J Med. 2015 Apr 2;372(14):1312-23. (PubMed).

LG Miller et al. Clindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin Infections. N Engl J Med. 2015 Mar 19;372(12):1093-103. (PubMed).

Good stuff

Anglo-Saxon remedy kills hospital superbug MRSA. Clare Wilson. New Scientist. 30 Mar 2015.

Genetically Determined Height and Coronary Artery Disease.

Clinical Pearl Jam

Surviving Sepsis Campaign Guideline revised.

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more